General
Preferred name
GINSENOSIDE F1
Synonyms
20(S)-Ginsenoside F1 ()
P&D ID
PD063504
CAS
53963-43-2
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity.
PRICE
112
DESCRIPTION
Ginsenoside F1 (20(S)-Ginsenoside F1) is an enzymatically modified derivative of ginsenoside Rg1, showing competitive inhibition of the activity of CYP3A4 and a weaker inhibition of the activity of CYP2D6.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
4
Cayman Chemical Bioactives
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
17
Molecular Weight
638.44
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
7
Rotatable Bonds
7
Ring Count
5
Aromatic Ring Count
0
cLogP
3.3
TPSA
160.07
Fraction CSP3
0.94
Chiral centers
16.0
Largest ring
6.0
QED
0.21
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
CYP3A4
Cytochrome P450
Endogenous Metabolite
P450 (e.g. CYP17)
Pathway
Metabolism
Metabolic Enzyme/Protease
Source data

